$PMVP SEC Filings

Filed On	Filing
05 Oct 2026	Form 4: Eckler Matthew Joseph, Director Granted 84,000 Stock Option (right to buy)
05 Oct 2026	Form 3: Eckler Matthew Joseph, Director No securities owned
05 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure Dr. Eckler brings more than two decades of combined experience in healthcare investing across public and private markets at Samsara BioCapital, ArrowMark, and GMT Capital, and scientific research
15 Sep 2026	SCHEDULE 13G
02 Sep 2026	424B5
02 Sep 2026	8-K: Entry into a Material Definitive Agreement; Other Events
31 Aug 2026	424B3
31 Aug 2026	424B5
31 Aug 2026	8-K: Other Events
14 Aug 2026	10-Q
14 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	SCHEDULE 13G/A
10 Jul 2026	SCHEDULE 13G/A
05 Jun 2026	Form 4: Stelzer Laurie, Director Granted 42,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Levine Arnold J, Director Granted 42,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Gallagher Carol Giltner, Director Granted 42,000 Stock Option (right to buy) · Gave 42,000 Stock Option (right to buy) as a gift · Acquired 42,000 Stock Option (right to buy) (Gift)
05 Jun 2026	Form 4: Flowers Kirsten, Director Granted 42,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Baum Charles M, Director Granted 42,000 Stock Option (right to buy)
05 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
15 May 2026	SCHEDULE 13G/A

Comments